Patents by Inventor Richard P. Shannon

Richard P. Shannon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for inhibiting delayed graft function
    Patent number: 9950038
    Abstract: Disclosed are compositions and methods for inhibiting preventing, reducing delayed graft function, allograft rejection or ischemia reperfusion injury.
    Type: Grant
    Filed: February 8, 2012
    Date of Patent: April 24, 2018
    Assignee: THE TRUSTEES OF THE UNIVERSIY OF PENNSYLVANIA
    Inventor: Richard P. Shannon
  • Cardio-Metabolic and Vascular Effects of GLP-1 Metabolites
    Publication number: 20170119853
    Abstract: The present invention relates to compositions and methods for treatment and/or prevention of a cardiovascular disease. In one embodiment, the compositions and methods of the invention relate to continuous administration of a GLP-1 or a metabolite thereof for the treatment and/or prevention of a cardiovascular disease.
    Type: Application
    Filed: January 17, 2017
    Publication date: May 4, 2017
    Inventor: Richard P. Shannon
  • Cardio-Metabolic and Vascular Effects of GLP-1 Metabolites
    Publication number: 20160151461
    Abstract: The present invention relates to compositions and methods for treatment and/or prevention of a cardiovascular disease. In one embodiment, the compositions and methods of the invention relate to continuous administration of a GLP-1 or a metabolite thereof for the treatment and/or prevention of a cardiovascular disease.
    Type: Application
    Filed: March 14, 2014
    Publication date: June 2, 2016
    Applicant: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
    Inventor: Richard P. Shannon
  • Methods and Compositions for Inhibiting Delayed Graft Function
    Publication number: 20140309169
    Abstract: Disclosed are compositions and methods for inhibiting preventing, reducing delayed graft function, allograft rejection or ischemia reperfusion injury.
    Type: Application
    Filed: February 8, 2012
    Publication date: October 16, 2014
    Inventor: Richard P. Shannon
  • Method of treating left ventricular dysfunction
    Patent number: 7192922
    Abstract: A method of treating a patient having heart failure due to LV systolic dysfunction with an LV ejection fraction less than 40%. The method includes the steps of administering to a patient in need thereof, a compound selected from the group consisting of GIP, GIP analogs, GIP derivatives and pharmaceutically-acceptable salts thereof, GLP-1, GLP-1 analogs, GLP-1 derivatives and pharmaceutically-acceptable salts thereof, at a therapeutically effective amount to improve LV function.
    Type: Grant
    Filed: November 19, 2002
    Date of Patent: March 20, 2007
    Assignee: Allegheny-Singer Research Institute
    Inventors: Richard P. Shannon, Dariush Elahi
  • Method of treating left ventricular dysfunction
    Publication number: 20040097411
    Abstract: A method of treating a patient having heart failure due to LV systolic dysfunction with an LV ejection fraction less than 40%. The method includes the steps of administering to a patient in need thereof, a compound selected from the group consisting of GIP, GIP analogs, GIP derivatives and pharmaceutically-acceptable salts thereof, GLP-1, GLP-1 analogs, GLP-1 derivatives and pharmaceutically-acceptable salts there of, at a therapeutically effective amount to improve LV function.
    Type: Application
    Filed: November 19, 2002
    Publication date: May 20, 2004
    Applicant: Allegheny-Singer Research Institute
    Inventors: Richard P. Shannon, Dariush Elahi